News Formal

Spanish drugmaker Grifols says Brookfield’s potential €6.45-billion offer undervalues the company

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 92%

Streetwise ニュース

日本 最新ニュース,日本 見出し

Earlier on Tuesday, Brookfield said it was considering a public offer for Grifols at €10.50 per A share and €7.62 per B share, implying a company valuation of €6.45-billion

potential €6.45-billion offer significantly undervalued the Spanish drugmaker’s prospects and long-term potential.

Grifols said its board would meet later on Tuesday to consider the potential offer, but that, given the valuation, it would not be in a position to recommend that shareholders accept it.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 5. in JP

日本 最新ニュース, 日本 見出し